NASDAQ:EPZM
Delisted
Epizyme Stock News
$1.47
+0 (+0%)
At Close: Nov 10, 2022
Aptinyx's (APTX) Mid-Stage Fibromyalgia Study Fails to Meet Goal
03:39pm, Friday, 12'th Aug 2022 Zacks Investment Research
Aptinyx (APTX) reports disappointing data from a mid-stage study assessing NYX-2925 for the treatment of fibromyalgia. Stocks decline
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
07:16pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
04:33pm, Wednesday, 10'th Aug 2022
Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.
Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates
12:25pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Epizyme (EPZM) delivered earnings and revenue surprises of 41.67% and 172.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Epizyme (EPZM) Reports Q2 Loss, Tops Revenue Estimates
09:47am, Tuesday, 09'th Aug 2022
Epizyme (EPZM) delivered earnings and revenue surprises of 41.67% and 172.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More
03:51pm, Wednesday, 29'th Jun 2022 Zacks Investment Research
Regulatory and other updates from Epizyme (MRNA) and Kezar (KZR) are a few key highlights from the biotech sector during the past week.
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
08:23am, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to cl
Why Adaptimmune Therapeutics Stock Is Popping Today
07:27pm, Monday, 27'th Jun 2022 The Motley Fool
Buyout fever is sparking interest in the biotech's beaten-down shares today.
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
04:26pm, Monday, 27'th Jun 2022 Benzinga
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
Acutus Medical, Inc. (NASDAQ: AFIB) gained 82.4% to $0.9819 after the company anno
Why Epizyme Stock Is Soaring Today
04:24pm, Monday, 27'th Jun 2022 The Motley Fool
A buyout ends Epizyme's 15-year tenure as an independent biopharma.
Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen
03:00pm, Monday, 27'th Jun 2022 Zacks Investment Research
Ipsen, through its wholly-owned subsidiary, is set to acquire Epizyme (EPZM) for $1.45 per share, in cash, along with a contingent value right of $1 per share. The transaction is likely to close by th
This 'underappreciated' black swan could bring fresh chaos to the global economy
01:24pm, Monday, 27'th Jun 2022 MarketWatch
It's summer and it's hot. That brings us to our call of the day from an energy trader who is super worried about electricity grids.
Why Epizyme Stock Is Soaring Today
12:24pm, Monday, 27'th Jun 2022
A buyout ends Epizyme's 15-year tenure as an independent biopharma.
Epizyme + 20 Stocks Moving In Monday's Pre-Market Session
10:31am, Monday, 27'th Jun 2022 Benzinga
Gainers
Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday.
Epizyme, Inc. (NASDAQ: EPZM) rose 57.2% to $1.50 in pre-market tradi
Ipsen Scoops Up Blood Cancer-Focused Epizyme - Read Why
07:02am, Monday, 27'th Jun 2022
Ipsen SA (OTC: IPSEY) has agreed to acquire Epizyme Inc (NASDAQ: EPZM) at $1.45 per share for approximately $247 million, plus one contingent value right (CVR) per share. The deal is expected to
